Grace Therapeutics, Inc. Net Asset Quality Index
Grace Therapeutics, Inc. net asset quality index. Grace Therapeutics, Inc. (GRCE) has a Net Asset Quality Index of 94.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $68.49 Million minus total liabilities of $3.60 Million yields net assets of $64.89 Million. A higher index indicates a stronger, lower-leverage balance sheet. See GRCE net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Grace Therapeutics, Inc. (2010–2025)
Net asset quality index of Grace Therapeutics, Inc. from 2010 to 2025. This chart shows how Grace Therapeutics, Inc.'s Net Asset Quality Index has evolved across 15 annual periods from 2010 to 2025. As of December 2025, the index stands at 94.7%, representing net assets of $64.89 Million against total assets of $68.49 Million USD. Check Grace Therapeutics, Inc. tangible book value ratio to evaluate the tangible quality of the company's equity base.
Grace Therapeutics, Inc. Net Asset Quality Index by Year (2010–2025)
Grace Therapeutics, Inc. net asset quality index by year from 2010 to 2025. The table below presents the year-by-year Net Asset Quality Index for Grace Therapeutics, Inc. from 2010 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see GRCE company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.5% | $66.61 Million | $71.99 Million | $5.38 Million | ▲ +8.3 pp |
| 2024 | 84.2% | $61.74 Million | $73.30 Million | $11.56 Million | ▼ -1.7 pp |
| 2023 | 85.9% | $67.95 Million | $79.12 Million | $11.17 Million | ▲ +1.7 pp |
| 2022 | 84.2% | $108.27 Million | $128.62 Million | $20.35 Million | ▼ -4.9 pp |
| 2021 | 89.1% | $55.66 Million | $62.46 Million | $6.80 Million | ▲ +32.3 pp |
| 2020 | 56.9% | $12.99 Million | $22.85 Million | $9.86 Million | ▲ +26.9 pp |
| 2019 | 29.9% | $11.04 Million | $36.90 Million | $25.85 Million | ▼ -5.9 pp |
| 2018 | 35.8% | $6.37 Million | $17.78 Million | $11.41 Million | ▼ -59.6 pp |
| 2016 | 95.5% | $20.09 Million | $21.04 Million | $957.12K | ▲ +6.1 pp |
| 2015 | 89.3% | $26.56 Million | $29.74 Million | $3.18 Million | ▲ +16.4 pp |
| 2014 | 72.9% | $29.91 Million | $41.01 Million | $11.10 Million | ▼ -7.0 pp |
| 2013 | 79.9% | $9.50 Million | $11.89 Million | $2.39 Million | ▼ -12.1 pp |
| 2012 | 92.0% | $14.55 Million | $15.82 Million | $1.27 Million | ▲ +39.3 pp |
| 2011 | 52.7% | $5.83 Million | $11.07 Million | $5.24 Million | ▲ +7.5 pp |
| 2010 | 45.1% | $4.02 Million | $8.90 Million | $4.88 Million | — |